drugset

drugset / Trial / NCT00483769

One Year Glargine Treatment in CFRD Children and Adolescents

NCT00483769 ↗

Phase 4 Completed 20 enrolled Federico II University

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Glargine treatment can improve the clinical features in Cystic Fibrosis patients affected by glucose derangements

Timeline

Start: 2006-02
Primary completion: —
Completion: 2007-01

Publications

Results Franzese A, Spagnuolo MI, Sepe A, Valerio G, Mozzillo E, Raia V. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? Diabetes Care. 2005 Sep;28(9):2333. doi: 10.2337/diacare.28.9.2333. No abstract available.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	insulin glargine	Protein / enzyme biologic	—	—

Indications